Benign prostatic hyperplasia (BPH) is a prevalent condition characterised by the non-malignant enlargement of the prostate gland, which frequently precipitates lower urinary tract symptoms (LUTS).

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

CHICAGO, May 5, 2019 /PRNewswire/ -- Astellas Pharma Inc. today announced results from the Phase 4, 12-week PLUS trial, the first large-scale, randomized trial in North America and Europe evaluating ...

Finasteride is FDA-approved to treat male pattern hair loss and benign prostatic hyperplasia (BPH) in adult males. Common side effects of finasteride can include erectile dysfunction, loss of libido, ...

Men aged 50 and above are most commonly affected. (Getty Images) This common condition affects up to three million people in the UK each year – but chances are, you've not heard of it. Benign ...

Nellore: Consultant Urologist at Medicover Hospitals, Nellore, Dr Gokul Nachiket G said that after 40 years, prostate gland ...

Doctors explain how subtle urinary and pelvic changes can signal early prostate problems in men, and why recognising symptoms ...

PHILADELPHIA (WPVI) -- Benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. BPH produces symptoms by obstructing the flow ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

Chicago, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is expected to reach us$ 16.5 billion by 2033, ...